Cargando…
miR-622 Suppresses Tumor Formation by Directly Targeting VEGFA in Papillary Thyroid Carcinoma [Retraction]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184228/ https://www.ncbi.nlm.nih.gov/pubmed/34113125 http://dx.doi.org/10.2147/OTT.S322704 |
Ejemplares similares
-
miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma
por: Wang, Renjie, et al.
Publicado: (2018) -
miR-302e Suppresses Glioma Progression by Targeting VEGFA [Retraction]
Publicado: (2021) -
Retraction Note: The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway
por: Li, Tian, et al.
Publicado: (2023) -
Retraction: miR-26a and its Target CKS2 Modulate Cell Growth and Tumorigenesis of Papillary Thyroid Carcinoma
Publicado: (2021) -
miR-302 Cluster Inhibits Angiogenesis and Growth of K562 Leukemia Cells by Targeting VEGFA [Retraction]
Publicado: (2023)